Every 10-Q that AMERICA GREAT HEALTH (AAGH) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow AAGH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AAGH filings page.
America Great Health reported very small operations and a highly leveraged balance sheet for the quarter and nine months ended March 31, 2026. Sales were $26,143 for the quarter and $258,802 for the nine months, generating nine‑month gross profit of $171,748.
The company recorded nine‑month net income of $861,105, versus a prior‑year loss, but management explains this was mainly driven by a non‑recurring $1,395,000 gain from extinguishment of aged accounts payable in the prior quarter, not by ongoing operations, which remained loss‑making in the latest quarter.
The balance sheet shows total assets of $167,105 against total liabilities of $5,047,740, resulting in a shareholders’ deficit of $4,880,635 and negative working capital of about $2.48 million. Cash was only $29,346, and the company relies on short‑term loans and $1,254,114 of advances from its majority shareholder, plus $2,423,349 of long‑term loans bearing interest mostly around 20%. Management states that recurring losses, limited cash, and the large deficit create substantial doubt about the company’s ability to continue as a going concern and plans to fund operations through additional capital and shareholder support.
Revenue is concentrated, with 71–76% from Asia and significant dependence on a handful of customers and suppliers. Management also notes prior auditor disclaimer of opinion on earlier annual financials and concludes that disclosure controls and procedures remain not effective due to material weaknesses including lack of an audit committee, independent directors, and sufficient accounting staff.
America Great Health reported sales of $232,659 for the six months ended December 31, 2025, roughly flat year over year, but gross profit fell to $149,215 as wholesale mix raised cost of goods sold.
The company posted net income of $1,027,321, driven mainly by a one‑time $1,395,000 gain from extinguishment of aged accounts payable, while operations still generated an operating loss of $202,159. Cash was only $22,904 with negative working capital of $2,404,215 and shareholders’ deficit of $4,715,116.
Management highlights substantial doubt about the ability to continue as a going concern, citing recurring losses historically, heavy short‑ and long‑term high‑interest loans, and dependence on advances from the majority shareholder.
America Great Health reported quarterly sales of $187,559 for the three months ended September 30, 2025, up from $140,126 a year earlier, but still posted a net loss of $85,363.
Gross profit was $112,679, while operating expenses fell to $116,063, narrowing the loss versus the prior-year period. Cash was only $28,079 with total liabilities of $6,070,405 and a shareholders’ deficit of $5,829,109, leading management to state there is substantial doubt about the company’s ability to continue as a going concern.
The company relies on high-interest short- and long-term loans, including $1,323,138 in long-term debt at rates up to 20%, and advances from its majority shareholder to fund operations.